Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

A Neuroendocrine Mechanism of Co-Morbidity of Depression-Like Behavior and Myocardial Injury in Rats

Abstract

Depression is generally a recurrent psychiatric disorder. Evidence shows that depression and cardiovascular diseases are common comorbid conditions, but the specific pathological mechanisms remain unclear. The purpose of this study is to determine the effects of depression induced by chronic unpredictable mild stress (CUMS) on myocardial injury and to further elucidate the biological mechanism of depression. Rats were used as a model. The CUMS procedure lasted for a total of 8 weeks. After 4 weeks of CUMS, treated rats exhibited a reduced sucrose preference and changes in scores on an open field test, body weight and content of 5-HT in the brain as compared with the values of these variables in controls. These changes indicated depression-like changes in CUMS rats and demonstrated the feasibility of the depression model. In addition, pathological changes in the myocardium and increased cardiomyocyte apoptosis demonstrated that myocardial injury had occurred after 6 weeks of CUMS and had increased significantly by the end of 8 weeks of CUMS. Plasma serotonin (5-HT), norepinephrine (NE) and epinephrine (E), all depression-related neuroendocrine factors, were measured by HPLC-ECD techniques, and the content of plasma corticosterone (GC) was evaluated by an I125–cortisol radioactivity immunoassay in control and CUMS rats. The results indicated that 5-HT had decreased, whereas NE, E and GC had increased in CUMS rats, and these factors might be associated with depression-induced myocardial injury. The effects of 5-HT, NE and GC on the survival rate of cultured cardiomyocytes were determined using an orthogonal design. The results showed that 5-HT was a more important factor affecting cell survival than GC or NE. The results suggested that normal blood levels of 5-HT had a cytoprotective effect. The neuroendocrine disorders characterized by decreased 5-HT combined with increased GC and NE mediated the occurrence of depression-induced myocardial injury.

Introduction

Cardiovascular disease (CVD) is a major cause of death in developed countries [1]. At the beginning of the 20th century, less than 10% of world mortality was related to CVD [2]. The association between CVD and depression is well established and is suggested to be bidirectional [3]. Depressed mood has been linked to CVD risk factors in patients with and without baseline cardiac disease [4], major depression is an independent risk factor for cardiovascular mortality and morbidity [5], [6]. Biological mechanisms that might link these two conditions together include the hypothalamic–pituitary–adrenal (HPA) axis, changes of arterial elasticity and endothelial function [7], [8]. While the exact mechanisms linking depression and increased cardiovascular risk remain poorly understood.

Although the exact biochemical mechanisms remain largely unknown, it is well established that depression and CVD share a common biochemical background that includes the main hormonal mediators of stress [9]. Stress includes etiological mechanisms for depression and heart injury [10], [11]. In animal models, only special stress protocols are available to induce depression-like symptoms. The chronic mild stress model has been widely accepted [12][14]. During the establishment of this model, rats are submitted to a regimen of chronic, mild and nontraumatic stressors such as deprivation of food and water, overnight illumination, cage tilt or a change of cage mate. This model is appropriate for the direct study of the pathogenesis, biological mechanisms and treatments of depression and is focused on the behavioral expressions of anhedonia (a central feature of depression characterized by an impaired responsiveness to pleasurable stimuli), which has been examined using sucrose preference tests [15][17].

Grippo [18] and colleagues found that rats exposed to chronic mild stress displayed an elevated heart rate, reduced heart rate variability and elevated sympathetic cardiac tone as well as anhedonia and reduced activity level in a running wheel after 4 weeks of stress. Their findings suggest that rats exposed to chronic mild stress are vulnerable to arrhythmic events that, in turn, may influence such additional detrimental cardiac events as myocardial infarction or death. Thus, in the present study, we investigated the comorbidity of depression and heart injury using rats as a model.

The adverse effects of antidepressants on the cardiovascular system have long been recognized. Although antidepressants are generally effective in decreasing depression, their use in patients with CHD is controversial [19], [20]. The safety of both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) has been questioned [21], [22]. However, some studies have shown that SSRI medication decreases depression symptoms and may improve CHD prognosis in patients with CHD and depression [21], [23]. It is therefore important to explore proper interventional drugs for both disorders. Sertraline is an SSRI that has been used for depression treatment. Heart toxicity due to sertraline has not been observed in animal or human research. Although antiplatelet and protective endothelium effects of sertraline have been reported [24], the results from three currently available epidemiological studies assessing the risk of MI in patients treated with SSRIs are controversial with regard to a potential beneficial effect of SSRIs on CVD risk in depressed patients. One study confirmed that sertraline caused concentration-dependent dilation in reconstructed arteries [22], [25]. A high dose of sertraline was able to fully reverse the level of vascular constriction caused by all types of vasoconstrictors. Sertraline also increased coronary flow in the isolated rat heart in a dose-dependent fashion.

The aim of this study was to hypothesize the Plasma serotonin (5-HT), corticosterone (GC), norepinephrine (NE) and epinephrine (E), all depression-related neuroendocrine factors is closely related to myocardial injury. The neuroendocrine disorders characterized by changed 5-HT, GC and/or NE is the physiology mechanism of depression-induced myocardial injury. Moreover, the present study attempted to assess the therapeutic effect of sertraline on depression and heart injury in vivo. The study provides a theoretical reference for the clinical treatment of the comorbidity of depression and cardiovascular diseases.

Materials and Methods

1 Animals

This study was conducted with the approval of the Animal Care and Use Committee of the Beijing Institute of Basic Medical Sciences, China. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Beijing Institute of Basic Medical Sciences (Permit Number: 2012-D-3096). All surgery was performed under sodium pentobarbital (1%, 1 ml/100 g weight, i.p.) anesthesia, and all efforts were made to minimize suffering.

Male Wistar rats (42 days, about 180 g) were used for the experiment, and 8 rats were treated in each group. Rats were acclimated to the surroundings for 1 week before the start of experiment. The animals were maintained on a 12 h light/dark cycle under a controlled temperature of 25±2°C. Food and water were available for the duration of the experiments unless otherwise noted. All animal handling procedures were performed in strict accordance with the guide for the use and care of laboratory animals.

2 Sucrose Preference Tests and Body Weight Measurement

Anhedonia, which is a central feature of depression, was defined as a reduction in sucrose preference. The methods for measuring sucrose preference were similar to those described by Muscat and Willner et al. [26], [27]. Rats were trained for adaptation to the taste of a sucrose solution (1%) prior to the start of the experiment. After removing the food and water from each rat’s cage for a period of 20 h, the rats were exposed to water and 1% sucrose solution in pre-weighed plastic bottles that were placed on the cages. The rats were then allowed to consume the fluids for a period of 1 h. The bottles were then removed and weighed to determine the amount (in grams) of each fluid consumed. The tests were conducted and body weights were measured before commencing the CUMS protocol (baseline) and every 2 weeks thereafter for 8 weeks. Sucrose preference was calculated according to the following formula: % sucrose preference = (sucrose intake/total fluid intake) × 100.

3 Protocol for Chronic Unpredictable Mild Stress (CUMS)

CUMS is used to model the negative life events of humans. CUMS produces anhedonia in rats, which demonstrates its effectiveness as an animal model [26], . In our experiment, rats were divided into control and CUMS groups according to their sucrose preference in the baseline test, in order to with the same depressive symptoms. The experimental protocol and CUMS procedure were variations of methods described by Grippo et al. [18], [28]. Briefly, The CUMS rats were caged individually, whereas the control rats were caged groups. The CUMS procedure was carried out for a total of 8 weeks. The stressors for CUMS included continuous overnight illumination, a 40° cage tilt along the vertical axis, paired housing, soiled cages (200 mL water spilled into the bedding of each cage), restraint in a small cage (equipped with breathing holes), exposure to an empty water bottle for 1 h immediately following a period of acute water deprivation and food deprivation. All of the stressors were applied individually and continuously, day and night. Control animals were left undisturbed in their home cages except for handling during regular cage cleaning and measuring body weight.

4 Open Field Test

Locomotors activity and exploratory behavior were evaluated using an open field test. The open field apparatus was a plywood box measuring 100 cm × 100 cm. All of the walls were painted black. The floor was divided into 25 equal squares. Rats were placed individually in one corner of the apparatus, and their ambulation (number of squares crossed) and immobility frequency were observed for 3 m. An open field test score was calculated as the sum of ambulation and immobility frequency [29].

5 Myocardial Morphological Structure Analysis of Rats

Myocardial damage was observed post-mortem after 2, 4, 6 and 8 weeks of CUMS using Nagar Olsen-stained paraffin sections of the myocardium. Each section was stained for 10 min with an alum hematoxylin solution. The section was then washed for 5 min with distilled water and stained for 3 min with basic fuchsin staining solution (0.1 g basic fuchsin stain in 100 mL of distilled water). The sections were then washed for 5 to 10 s with distilled water and for 5 s with acetone wash. The sections were then incubated in a 1% picric acid solution (1 g picric acid in 100 mL of acetone) for 5 to 15 s for quick differentiation and sealed with xylene and neutral gum. Red areas were measured with AxioVision under an optical microscope.

The pathological alteration of the rat cardiomyocytes was analyzed using an electron microscope (Hitachi, Japan) according to Coleman’s method [30]. The ventricular muscles of the rat hearts were dissected and fixed overnight in pre-cooled 3% glutaraldehyde and then in 1% osmium. Ultrastructural changes in the myocardium were observed by electron microscopy after being marked with uranium and lead.

6 Pharmacological Treatment

Rats were divided into 4 groups randomly after 4 weeks of exposure to CUMS: a control group given only water to drink, a control group that received sertraline hydrochloride (i.g., 10 mg/kg/day) but was not exposed to CUMS, a CUMS group that was not treated with sertraline and a CUMS group that was treated with sertraline. Sertraline is an SSRI and seems to be a safe and efficacious treatment for depression [31][33]. The CUMS procedure was carried out for a total of 8 weeks.

7 Terminal Deoxynucleotidyl Transferase dUTP nick-end Labeling Assay

After 2, 4, 6 and 8 weeks of CUMS, a terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) assay was used to determine tissue cardiomyocyte apoptosis as previously described [34], the same tissue samples were used as those mentioned in Section 2.5.

8 The Determination of Plasma Hormone Levels

Plasma serotonin (5-HT) was detected as previously described [35], briefly, Aliquots of sample (5 µl) were injected onto a microbore HPLC column (Unijet, 100×1 mm, 5 µM ODS, Bioanalytical Systems, Inc, West Lafayette, IN, USA) that was coupled to an amperometric detector (Model LC-4C, BAS, Inc.). A glassy carbon electrode was set at a potential of +650 mV relative to Ag/AgCl reference. Mobile phase consisted of 180 µM Na2EDTA, 150 mM monochloroacetic acid, 125 mM NaOH, and 318 µM sodium octanesulfonic acid, with 4.5% MeOH and 4.5% CH3CN per liter of water (final pH = 3.15). Mobile phase was pumped through the column at 60 µl/min (Model 260 D, Teledyne ISCO, Lincoln, NE, USA). Chromatographic data were acquired on-line and exported to a Millennium software system (Waters Associates, Milford, MA, USA). The concentration of 5-HT in dialysate samples was compared to known standards, and the lower limit of detection was 0.05 pg/5 µL (0.047 nM). Norepinephrine (NE) and epinephrine (E) were also measured by high-performance liquid chromatography (HPLC) with electrochemical detection (ECD) [36]. Plasma corticosterone (GC) level was evaluated by a I125–cortisol radioactivity immunoassay in both control and CUMS rats [37].

9 Statistical Analyses

Values are presented as the mean ± SE for the indicated experiments and were analyzed by a mixed-design ANOVA, a one-way ANOVA and Student’s t-tests as appropriate. A probability value of P<0.05 was considered to be statistically significant.

Results

1 Chronic Unpredictable Mild Stress Induces Comorbidity of Depression-like Behavior and Myocardial Injury in Rats

We found that chronic unpredictable mild stress caused a significant loss of body weight (Fig. 1A) (F = 6.89, t = 2.98, df = 15, P<0.05). The total open field test scores are shown in Figure 1B. The open field test score of CUMS rats decreased significantly compared with the control group after 8 weeks of CUMS (F = 7.42, t = 3.25, df = 15, P<0.05). The sucrose preference test indicates the degree of the animals’ responsiveness to reward. Chronic unpredictable mild stress significantly decreased sucrose preference (Fig. 1C) (F = 7.36, t = 3.12, df = 15, P<0.05). This decrease in sucrose preference is similar to symptoms of depression and anhedonia. Myocardial tissue injury (the myocardial red area in the figures) was observed after 6 and 8 weeks of CUMS (Fig. 1D).

thumbnail
Figure 1. Unpredictable chronic mild stress induces comorbidity of depression-like behavior and myocardial injury in rats.

The depression-like behavior and myocardial injury of CUMS rats were measured at 2, 4, 6 and 8 weeks. A. The rats were weighed weekly, and the weights are shown. B. Locomotor activity and exploratory behavior were evaluated as described in the Materials and Methods section. Values are the mean ± SD from 3 independent experiments, *P<0.05 compared with the control. C. A 2-bottle sucrose preference test was used to measure rats’ preferences for sweetened solution over water. Preference was calculated as the percentage of sucrose solution consumed compared to the total fluid intake (sucrose/(sucrose+water) x 100). D. Myocardial damage was observed by Nagar Olsen staining. The size and scale of the red-stained range represent the severity of the injury. There was no injury in control group rats (a) or in 2 and 4 week CUMS rats (b, c). Myocardial injury occurred after 6 weeks of CUMS (d) and increased after 8 weeks of CUMS (e). E. An electron microscope was used to detect pathological ultrastructural alteration. A myocardial ultrastructure showing normal cardiac nuclear, myofibril structure and mitochondria (×10000) in control group rats is shown (a). Abnormal ultrastructural changes such as myofibril breakage were observed after 8 weeks of CUMS (×10000) (b). Mitochondrial disarrangement, mitochondrial interrupted inner membrane and cristae and mitochondrial vacuoles (×10000) are shown (c, f). Nuclear membrane shrinkage and chromatin margination (×10000) were also seen in 8-week CUMS rats (d, e, f). F. Restraint stress increased cardiomyocyte apoptosis as measured by TUNEL. Values represent the group mean ± structural equation modeling (SEM) (n = 8 rats per group). *P<0.05 compared with control, repeated measures ANOVA followed by Tukey’s multiple comparison test.

https://doi.org/10.1371/journal.pone.0088427.g001

Electron microscopy was used to observe myocardial ultrastructural changes resulting from CUMS to clarify the pathological features of myocardial injury. As shown in Figure 1F, the myocardial ultrastructure of the control group displays round nuclear myofibrils arranged in neat rows, normal muscle wire arrangement with clear cell boundaries, mitochondria of basically the same normal shape, size and arrangement; and mitochondrial cristae arranged in layers (a). The myocardial ultrastructure of the CUMS group shows myofibril breakage (b), mitochondrial disarrangement, an interrupted inner membrane and interrupted mitochondrial cristae, mitochondrial vacuoles (c, f) and nuclear membrane shrinkage and chromatin margination (d, e, f). These changes illustrate that CUMS can induce myocardial injury as well as depression-like behavior.

2 A Low Level of 5-HT with a High Level of GC and NE was the Neuroendocrine Pattern that Induced the Myocardial Injury

The synergism model of 5-HT-, GC- and NE-induced myocardial injury is not yet universally accepted. We therefore examined changes in 5-HT, GC and NE in the plasma of rats with depression and myocardial injury. The results indicated that 5-HT decreased, whereas NE, E and GC increased in CUMS rats (Fig. 2), suggesting that these factors might be associated with depression-induced myocardial injury. The effects of 5-HT, NE and GC on the survival rate of cultured cardiomyocytes were determined using an orthogonal experiment (Table 1). The results showed that 5-HT acted as the most important factor in affecting cell survival (Table 2, Fig. 3) but only if GC or NE were present (Fig. 3).

thumbnail
Figure 2. Effect of unpredictable chronic mild stress on plasma neuroendocrine transmitter in rats.

The concentrations of serotonin, norepinephrine and epinephrine were measured by HPLC-ECD, and the concentration of glucocorticoid was evaluated by an I125–cortisol radioactivity immunoassay in both control and CUMS rats. A. The glucocorticoid content in plasma increased significantly after 2 and 4 weeks of CUMS but returned to normal levels after 6 and 8 weeks of CUMS. B. The 5-HT content in plasma increased significantly after 6 and 8 weeks of CUMS. C. The norepinephrine content in plasma increased significantly after 6 and 8 weeks of CUMS. D. The epinephrine content in plasma increased significantly after 6 and 8 weeks of CUMS. Values represent the group mean ± structural equation modeling (SEM) (n = 8 rats per group). *P<0.05 compared with control, repeated measures ANOVA followed by Tukey’s multiple comparison test.

https://doi.org/10.1371/journal.pone.0088427.g002

thumbnail
Figure 3. 5-HT-induced cardiomyocyte injury required the presence GC or NE in vitro.

An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to detect cell viability. 5-HT (10−5, 10−6, 10−7 and 10−8 M) was used to treat cultured cardiomyocytes with 10−6 M GC or 10−6 M NE. A. The cell viability of cardiomyocytes treated with 10−8 M 5-HT and 10−6 M GC decreased significantly compared with the control. B. The cell viability of cardiomyocytes treated with 10−8 M 5-HT and 10−6 M NE decreased significantly compared with the control. C. The cell viability of cardiomyocytes treated with only 5-HT was not changed significantly compared with the control. D. The apoptosis rate of cardiomyocytes treated with 5-HT and 10−6 GC increased significantly compared with the control. E. The apoptosis rate of cardiomyocytes treated with 5-HT and 10−6 NE increased significantly compared with the control. Values represent the group mean ± structural equation modeling (SEM) (n = 8 rats per group). *P<0.05 compared with control, repeated measures ANOVA followed by Tukey’s multiple comparison test.

https://doi.org/10.1371/journal.pone.0088427.g003

thumbnail
Table 1. The factors and the levels of the orthogonal design experiment.

https://doi.org/10.1371/journal.pone.0088427.t001

thumbnail
Table 2. Changes in the survival rate of cultured cardiomyocytes by an orthogonal experiment.

https://doi.org/10.1371/journal.pone.0088427.t002

3 Sertraline Hydrochloride Inhibits Depression-like Behavior and Myocardial Injury in Rats with Chronic Unpredictable Mild Stress

Sertraline hydrochloride is an antidepressant of the selective serotonin reuptake inhibitor class. We found that sertraline can effectively reverse the behavioral indicators of depression and the cardiac abnormalities induced by CUMS. Sertraline can also significantly increase the body weight of CUMS rats (Fig. 4A). The total scores of the open field test are shown in Figure 4B. Sertraline significantly increased the open field test score of rats after 8 weeks of exposure to CUMS (F = 7.53, t = 3.46, df = 15, P<0.05). Sertraline also reversed the CUMS-induced decrease in sucrose preference (Fig. 4C). These results indicate that sertraline hydrochloride can effectively reverse or improve the depression-like symptoms of rats exposed to CUMS.

thumbnail
Figure 4. Sertraline inhibits depression-like behavior and myocardial injury in CUMS rats.

Body weights, open field test scores and sucrose preference were measured as described in Figure 1. A. Sertraline inhibited weight loss induced by CUMS. B. Sertraline inhibited the decline of the open field test score induced by CUMS. C. Sertraline inhibited the decline of sucrose preference induced by CUMS. D. Sertraline inhibited the myocardium injury induced by CUMS. E. Sertraline inhibited the apoptosis induced by CUMS. Values represent the group mean ± structural equation modeling (SEM) (n = 8 rats per group). *P<0.05 compared with control, #P<0.05 compared with the 8-week CUMS group, repeated measures ANOVA followed by Tukey’s multiple comparison test.

https://doi.org/10.1371/journal.pone.0088427.g004

The rats’ myocardial tissue sections were stained with basic fuchsin to observe the effect of sertraline hydrochloride on myocardial injury. Our results showed that rats exposed to CUMS for 8 weeks had damaged cardiac histiocytes but that sertraline hydrochloride protected the rats from CUMS-induced myocardial injury (Fig. 4D).

Discussion

Based on the etiological mechanisms of depression and heart injury, the present study investigated the comorbidity of depression and heart injury in rats with CUMS and assessed the interventional effect of sertraline. The results demonstrated that CUMS caused significantly reduced body weight and sucrose preference. CUMS rats also exhibited heart injury, increased myocardial apoptosis and cardiac morphological abnormalities. The anti-depressant sertraline effectively reversed all these CUMS-induced behavioral changes and cardiac abnormalities.

Anhedonia, which is described as a decreased ability to relate rewards with different environments [38][42], was inferred from decreased sucrose preference in our experiment. This behavioral change is an important indicator for the establishment of a CUMS model of depression that mimics major depression in humans and reflects responsiveness to pharmacological treatments. Rats in the current study displayed reduced sucrose preference after 4 weeks of CUMS exposure, which is consistent with previous studies [18], [28], [43]. There was no significant relationship between sucrose intake and loss of body weight in CUMS rats. The reduced sucrose preference of rats therefore reflected depression-like symptoms induced by present CUMS procedures.

The present study also demonstrates that CUMS produced the observed myocardial injury. We examined cardiac morphological structure and myocardial apoptosis. The results demonstrated that CUMS significantly damaged myocardial ultrastructure, particularly by causing mitochondrial abnormalities and then inducing myocardial apoptosis. Mitochondria are vital for maintaining the physiological function of cardiomyocytes [44][46]. Many stimuli can cause the mitochondrial MPTP to open [47], with a subsequent series of cytological effects that includes a loss of mitochondrial transmembrane potentials, uncoupling of the respiratory chain, leakage of mitochondrial Ca2+, excess generation of ROS [48], [49], release of resident mitochondrial proteins such as the apoptosis initiating factor cytochrome c and release of a second mitochondria-derived activator of caspase [50]. These effects indicate that mitochondrial damage be a key step leading to myocardial death.

Our findings confirm that CUMS can produce both depression-like symptoms and heart injury. CUMS is appropriate as a stress model to study the occurrence and mechanisms of the comorbidity of depression and heart injury [51], [52].

Plasma serotonin (5-HT) dysfunction is the most widely accepted neuroendocrine mechanism for depression [53], [54]. HPA axis dysfunction [55] and elevated levels of plasma catecholamine [56] are also hypothesized to be involved in depression. GC has complex, and often contradictory, influences on cardiovascular disease and cardiovascular risk [57]. Extensive evidence has established that NE play major role in left ventricular hypertrophy and heart failure [58]. Therapy with selective serotonin reuptake inhibitors (SSRIs) is strongly recommended to reduce cardiovascular disease-induced morbidity and mortality [59]. However, the relationship between the NE, GC and 5-HT effect on myocardial injury have not been elucidated. In this study, we find low level of 5-HT with a high level of GC and NE can induced the myocardial injury Normal blood levels of 5-HT, GC and NE have a cytoprotective effect, the neuroendocrine disorders characterized by decreased 5-HT in combination with increased GC or NE mediated depression-induced myocardial injury. We also assessed the effects of the antidepressant sertraline on depression and cardiac injury. Rats treated with sertraline 2 weeks before exposure to CUMS were found to have an increased sucrose preference after 8 weeks of CUMS exposure. However, sertraline did not completely reverse the observed reduction in body weight. This finding is further evidence of lack of an association between the reductions in sucrose intake and in body weight that are caused by CUMS.

Sertraline, a selective serotonin reuptake inhibitor (SSRI), is the most commonly prescribed therapy for maternal depression. Some studies have linked SSRI exposure with myocardial protection [60]. On the other hand, it was investigated that sertraline is a potent blocker of cardiac K+ channels and the patients taking sertraline especially with risks of long QT syndrome should be cautiously monitored for clinical signs of cardiac arrhythmia [61]. The present results of myocardial apoptosis screening also show that sertraline hydrochloride confers significant protection against myocardial cell injury (Fig. 4D). This activity suggests that sertraline hydrochloride can effectively protect CUMS rats from myocardial pathological injury by reducing cardiomyocyte apoptosis. The decrease in the 5-HT level might be the most important cause of myocardial injury in CUMS rats, and increased levels of GC and NE may be contributive. Therefore, we presumed that sertraline might be an ideal drug for the treatment of comorbid depression and cardiovascular diseases in humans. The mechanism of sertraline treatment for both disorders may include direct and indirect effects. Vasodilatory, antiplatelet and endothelium- protective effects of sertraline [62], [63] may contribute to the direct effect. The indirect effect may result from the use of sertraline to treat depression, and recovery from depression might contribute to an amelioration of heart injury.

In conclusion, CUMS is an effective animal model for studying the comorbidity of depression and heart injury. The present research indicates that depressive behavior can cause myocardial injury. The neuroendocrine disorders characterized by decreased 5-HT in combination with increased GC or NE is the physiology mechanism of depression-induced myocardial injury. Sertraline, which had previously been shown to be an effective anti-depressant, is now confirmed to be a suitable treatment for human patients suffering simultaneously from depression and cardiovascular disease.

Acknowledgments

The authors thank Shen Chengfeng and Wang Dezheng for their assistance with the statistical analysis. We also thank two anonymous reviewers for their patient review and critical reading of our manuscript.

Author Contributions

Conceived and designed the experiments: WX QL. Performed the experiments: LW ZR. Analyzed the data: WL JB. Contributed reagents/materials/analysis tools: QL. Wrote the paper: WX.

References

  1. 1. Murray CJL, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. The Lancet 349: 1269–1276.
  2. 2. Delui MH, Yari M, Khouyinezhad G, Amini M, Bayazi MH (2013) Comparison of Cardiac Rehabilitation Programs Combined with Relaxation and Meditation Techniques on Reduction of Depression and Anxiety of Cardiovascular Patients. The Open Cardiovascular Medicine Journal 7: 99–103.
  3. 3. Baune BT, Stuart M, Gilmour A, Wersching H, Heindel W, et al. (2012) The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Citation: Transl Psychiatry 2: 1–19.
  4. 4. Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, et al. (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Archives of General Psychiatry 58: 221.
  5. 5. Williams MS (2012) Platelets and depression in cardiovascular disease: A brief review of the current literature. World J Psychiatr 2: 114–123.
  6. 6. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, et al. (2006) Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 21: 30–38.
  7. 7. Joynt KE, Whellan DJ, O'Connor CM (2003) Depression and cardiovascular disease: mechanisms of interaction. Biological psychiatry 54: 248–261.
  8. 8. Rudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biological psychiatry 54: 227–240.
  9. 9. Whooley MA (2006) Depression and cardiovascular disease. JAMA: the journal of the American Medical Association 295: 2874–2881.
  10. 10. Kotter T, Voltmer E (2013) Measurement of specific medical school stress: translation of the “Perceived Medical School Stress Instrument” to the German language. GMS Zeitschrift fur medizinische Ausbildung 30: Doc22.
  11. 11. Redfors B, Shao Y, Omerovic E (2013) Stress-induced cardiomyopathy (Takotsubo)–broken heart and mind? Vascular health and risk management 9: 149–154.
  12. 12. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience & Biobehavioral Reviews 16: 525–534.
  13. 13. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110.
  14. 14. D'Aquila PS, Brain P, Willner P (1994) Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiology & behavior 56: 861–867.
  15. 15. Chen LP, Sun Y, Wang FW, Duan DM, Hu YZ (2011) Effect of Shuyusan on neuropeptide Y and serotonin expression in the hippocampal neurons of rats with chronic mild unpredictable stress-induced depression. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 31: 113–116.
  16. 16. Wang S, Hu S, Zhang C, Qiu J, Li Y (2011) Effect of Chaihu Shugan San and its components on expression of ERK1/2 mRNA in the hippocampus of rats with chronic mild unpredicted stress depression. Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences 36: 93–100.
  17. 17. Yu L, An SC, Lian T (2010) Involvement of hippocampal NMDA receptor and neuropeptide Y in depression induced by chronic unpredictable mild stress. Sheng li xue bao : [Acta physiologica Sinica] 62: 14–22.
  18. 18. Grippo AJ, Johnson AK (2002) Biological mechanisms in the relationship between depression and heart disease. Neuroscience and biobehavioral reviews 26: 941–962.
  19. 19. Kapfhammer HP (2011) The relationship between depression, anxiety and heart disease - a psychosomatic challenge. Psychiatria Danubina 23: 412–424.
  20. 20. Lin EH, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, et al. (2012) Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Annals of family medicine 10: 6–14.
  21. 21. Lundberg J, Tiger M, Landen M, Halldin C, Farde L (2012) Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 15: 1167–1172.
  22. 22. Zahl PH, De Leo D, Ekeberg O, Hjelmeland H, Dieserud G (2010) The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC psychiatry 10: 62.
  23. 23. Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM (2011) Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs in R&D 11: 1–11.
  24. 24. Hayes D (2004) Recent developments in antidepressant therapy in special populations. The American journal of managed care 10: S179–185.
  25. 25. Troost J, Tatami S, Tsuda Y, Mattheus M, Mehlburger L, et al. (2011) Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin. British journal of clinical pharmacology 72: 247–256.
  26. 26. D'Aquila PS, Newton J, Willner P (1997) Diurnal variation in the effect of chronic mild stress on sucrose intake and preference. Physiology & behavior 62: 421–426.
  27. 27. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93: 358–364.
  28. 28. Grippo AJ, Moffitt JA, Johnson AK (2002) Cardiovascular alterations and autonomic imbalance in an experimental model of depression. American journal of physiology Regulatory, integrative and comparative physiology 282: R1333–1341.
  29. 29. Choleris E, Thomas AW, Kavaliers M, Prato FS (2001) A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neuroscience & Biobehavioral Reviews 25: 235–260.
  30. 30. Coleman R, Silbermann M, Gershon D, Reznick AZ (1987) Effects of long-term running stress on the ultrastructure of the aging mouse heart. Gerontology 33: 19–33.
  31. 31. Meijer WEE, Heerdink ER, Leufkens HGM, Herings RMC, Egberts ACG, et al. (2004) Incidence and determinants of long-term use of antidepressants. European journal of clinical pharmacology 60: 57–61.
  32. 32. Sauer WH, Berlin JA, Kimmel SE (2001) Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104: 1894–1898.
  33. 33. Strik JJMH, Honig A, Lousberg R, Lousberg AHP, Cheriex EC, et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosomatic Medicine 62: 783–789.
  34. 34. Torchinsky A, Shepshelovich J, Orenstein H, Zaslavsky Z, Savion S, et al. (2003) TNF-alpha protects embryos exposed to developmental toxicants. American journal of reproductive immunology 49: 159–168.
  35. 35. Yubero-Lahoz S, Ayestas Jr MA, Blough BE, Partilla JS, Rothman RB, et al. (2012) Effects of MDMA and related analogs on plasma 5-HT: Relevance to 5-HT transporters in blood and brain. European journal of pharmacology 674: 337–344.
  36. 36. Bott-Flügel L, Bernshausen A, Schneider H, Luppa P, Zimmermann K, et al. (2011) Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism. PloS one 6: e18048.
  37. 37. Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, et al. (2011) Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. Journal of psychosomatic research 71: 13–17.
  38. 38. Bravo L, Mico JA, Rey-Brea R, Perez-Nievas B, Leza JC, et al. (2012) Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology 117: 613–625.
  39. 39. Liu WH, Wang LZ, Zhao SH, Ning YP, Chan RC (2012) Anhedonia and emotional word memory in patients with depression. Psychiatry research 200: 361–367.
  40. 40. Keedwell PA, Chapman R, Christiansen K, Richardson H, Evans J, et al. (2012) Cingulum white matter in young women at risk of depression: the effect of family history and anhedonia. Biological psychiatry 72: 296–302.
  41. 41. McMakin DL, Olino TM, Porta G, Dietz LJ, Emslie G, et al. (2012) Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. Journal of the American Academy of Child and Adolescent Psychiatry 51: 404–411.
  42. 42. Morgan JK, Olino TM, McMakin DL, Ryan ND, Forbes EE (2013) Neural response to reward as a predictor of increases in depressive symptoms in adolescence. Neurobiology of disease 52: 66–74.
  43. 43. Grippo AJ, Beltz TG, Johnson AK (2003) Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiology & behavior 78: 703–710.
  44. 44. Carreira RS, Monteiro P, Kowaltowski AJ, Goncalves LM, Providencia LA (2008) Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. Journal of bioenergetics and biomembranes 40: 95–102.
  45. 45. Kong HL, Li ZQ, Zhao YJ, Zhao SM, Zhu L, et al. (2010) Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening. Acta pharmacologica Sinica 31: 687–695.
  46. 46. Passarelli C, Tozzi G, Pastore A, Bertini E, Piemonte F (2010) GSSG-mediated Complex I defect in isolated cardiac mitochondria. International journal of molecular medicine 26: 95–99.
  47. 47. Wang X, Liu X, Kong R, Zhan R, Wang X, et al. (2009) NGFI-B targets mitochondria and induces cardiomyocyte apoptosis in restraint-stressed rats by mediating energy metabolism disorder. Cell stress & chaperones 14: 639–648.
  48. 48. Lu FH, Tian Z, Zhang WH, Zhao YJ, Li HL, et al. (2010) Calcium-sensing receptors regulate cardiomyocyte Ca2+ signaling via the sarcoplasmic reticulum-mitochondrion interface during hypoxia/reoxygenation. Journal of biomedical science 17: 50.
  49. 49. Wang X, Gong J, Liu X, Zhan R, Kong R, et al. (2010) Expression of uncoupling protein 3 in mitochondria protects against stress-induced myocardial injury: a proteomic study. Cell stress & chaperones 15: 771–779.
  50. 50. Xinxing W, Hong F, Rui Z, Yun Z, Jingbo G, et al. (2012) Phosphorylated nerve growth factor-induced clone B (NGFI-B) translocates from the nucleus to mitochondria of stressed rat cardiomyocytes and induces apoptosis. Stress 15: 545–553.
  51. 51. Spasojevic N, Jovanovic P, Dronjak S (2012) Chronic fluoxetine treatment affects gene expression of catecholamine enzymes in the heart of depression model rats. Indian journal of experimental biology 50: 771–775.
  52. 52. Zhang WY, Liu S, Li HD, Cai HL (2012) Chronic unpredictable mild stress affects myocardial metabolic profiling of SD rats. Journal of pharmaceutical and biomedical analysis 70: 534–538.
  53. 53. Cowen P. Serotonin, depression and antidepressant action. South African Journal of Psychiatry. SA Medical Assoc Health & Medical Publ Group 21 Dreyer St, 4th floor, Sanclare Bldg, Claremont, 7700, South Africa. 94–94.
  54. 54. Jasinska AJ, Lowry CA, Burmeister M (2012) Serotonin transporter gene, stress and raphe-raphe interactions: a molecular mechanism of depression. Trends in neurosciences 35: 395–402.
  55. 55. Wasserman D, Wasserman J, Sokolowski M (2010) Genetics of HPA-axis, depression and suicidality. European Psychiatry 25: 278–280.
  56. 56. Goldstein I, Lax E, Gispan-Herman I, Ovadia H, Rosen H, et al. (2012) Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behavior. European Neuropsychopharmacology 22: 72–79.
  57. 57. Hadoke PWF, Iqbal J, Walker BR (2009) Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British journal of pharmacology 156: 689–712.
  58. 58. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, et al. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. cell 93: 215–228.
  59. 59. Bhuiyan MS, Tagashira H, Fukunaga K (2013) Crucial Interactions Between Selective Serotonin Uptake Inhibitors and Sigma-1 Receptor in Heart Failure. Journal of pharmacological sciences. J Pharmacol Sci 121: 177–84.
  60. 60. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, et al. (2003) Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 108: 939–944.
  61. 61. Lee H, Kim K-S, Hyun S, Park S-G, Kim SJ (2012) Wide spectrum of inhibitory effects of sertraline on cardiac ion channels. The Korean Journal of Physiology & Pharmacology 16: 327–332.
  62. 62. Palekar N, Eisman J (2013) Serotonin syndrome with ziprasidone and sertraline. The Journal of neuropsychiatry and clinical neurosciences 25: E01.
  63. 63. Santra R, Chaudhuri PR, Dhali D, Mondal S (2012) Suicidality and suicide attempt in a young female on long-term sertraline treatment. Indian journal of psychological medicine 34: 391–393.